DURECT
Jim Snider has over 25 years of experience in the pharmaceutical and manufacturing sectors. Since 2006, Jim Snider has served as a Sr. Manufacturing Development Specialist at DURECT Corp., contributing to innovative manufacturing processes. Prior to this role, Jim Snider worked at Johnson & Johnson (ALZA) from 1996 to 2006 as a Sr. Materials Specialist, where expertise in materials management was developed. Jim Snider's educational background includes studies at City College of San Francisco during 1978 to 1979.
DURECT
1 followers
DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program.